LY3875383

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3875383, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia [Phase 1]